renal cancer

Kidney cancer kills about 14,000 people every year. It is especially deadly when it is found in the late stages. Scott was first diagnosed with kidney cancer in January of 2011 and given only 10 months to live...that was over 8 years ago.
Results from the CheckMate 214 clinical trial show that combined therapy with two immunotherapy drugs, nivolumab and ipilimumab, can be very effective in the treatment of renal cell carcinoma, the most common type of kidney cancer.